{"disease":{"id":"immune-related-adverse-events","name":"immune related adverse events"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04115410","title":"PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":4724,"lead_sponsor_name":"Sungkyunkwan University","has_results":false},{"nct_id":"NCT07357636","title":"Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors","phase":"","overall_status":"RECRUITING","enrollment_count":940,"lead_sponsor_name":"Shantou University Medical College","has_results":false},{"nct_id":"NCT07453342","title":"Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06789601","title":"Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04840355","title":"Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Guohui Li","has_results":false},{"nct_id":"NCT07167251","title":"Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids","phase":"","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT04807127","title":"A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT07430579","title":"Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"The Second Hospital of Shandong University","has_results":false},{"nct_id":"NCT05414552","title":"ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Freiburg","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}